Parvovirus B19, VP1, VP2, recombinant protein from Baculovirus
Recombinant Parvovirus B19 VP1&VP2 protein. Expressed by recombinant baculovirus (Autographa californica multiple nuclear polyhedrosis virus; AcMNPV) infection of Spodoptera frugiperda Sf9 insect cells. Full-length cDNAs coding for human parvovirus B19 VP
Light scattering properties of virus-like particles (VLPs) cause slight turbidity of product suspensions; this does not affect product quality.
neutral to slightly alkaline pH and 20 % glycerol as cryoprotective agent.
2-8°C short term, -20°C long term
Parvovirus B19 infection is common among children and adults and is often asymptomatic. Parvovirus B19 infection can result in serious and occasionally fatal hematologic diseases in susceptible patients, and is the cause of fifth disease, a highly contagious infection of childhood. Parvovirus B19 can also infect the fetus causing severe anemia, congestive heart failure, and death in utero or at birth.
Human parvovirus B19 capsid proteins VP1 and VP2 as virus-like particle (VLP)
Parvoviridae; Erythrovirus; Parvovirus B19; Parvovirus B19, VP1/VP2; Parvovirus (B19); B19 virus; Parvovirus B19 VLP VP2; parvovirus B19 capsid protein VP2 as virus-like particle; VLP VP2; capsid protein VP2 as virus-like particle